Regulated information

RSS Feed

You can choose the releases by year and category :

  • 02 February 2012 - Paris (France)

    Ipsen’s fourth quarter and full year 2011 sales and other significant developments

  • 27 January 2012 - Paris (France)

    Ipsen acknowledges Tanakan® delisting in France

  • 24 January 2012 - Paris (France)

    Santhera and Ipsen Renegotiate Fipamezole Licensing Agreement

  • 12 January 2012 - Paris (France)

    Half-year statement of Ipsen's liquidity contract

  • 05 January 2012 - Paris (France)

    The total number of voting rights and total number of shares

  • 05 January 2012 - Dijon and Paris (France)

    Oncodesign and Ipsen enter into a research collaboration for the development of new therapeutic agents against the LRRK2 Parkinson's disease target

  • 04 January 2012 - Paris (France)

    Ipsen announces its corporate agenda for 2012